Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Chime & Chill has shown a consistent presence in the New York market, particularly within the Tincture & Sublingual category. Over the last few months of 2025, the brand maintained a stable position, ranking 12th from September through November, before experiencing a slight dip to 13th in December. This indicates a relatively strong performance in a competitive category, although the drop in December could suggest seasonal fluctuations or increased competition. Despite the dip in ranking, the brand's sales figures in October and November demonstrated an upward trend, peaking in November before decreasing in December, which could warrant further analysis to understand the underlying factors contributing to these shifts.
Notably, Chime & Chill's absence from the top 30 brands in other states or provinces suggests that their market penetration is currently limited to New York within this category. This could be viewed as a missed opportunity or a strategic focus, depending on the brand's overall goals. The lack of presence in additional markets might indicate potential areas for expansion or an opportunity to strengthen their position in the existing market. Understanding the dynamics of other states and how they compare to New York could provide valuable insights for the brand's growth strategy moving forward.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Chime & Chill has maintained a relatively stable position, ranking 12th from September to November 2025, before slipping to 13th in December. This slight decline in rank coincides with a decrease in sales from November to December, suggesting potential challenges in maintaining market share. In contrast, Canna Clinicals experienced a notable fluctuation, dropping from 8th to 11th in November but rebounding to 9th in December, indicating a more volatile yet resilient performance. Meanwhile, Jumbodose saw a consistent decline in rank from 10th in September to being absent from the top 20 by December, reflecting a significant drop in sales. Interestingly, Canna Dots emerged in December at 12th place, suggesting a new competitive pressure for Chime & Chill. These dynamics highlight the importance for Chime & Chill to innovate and adapt to maintain and potentially improve its standing in a competitive market.

Notable Products
In December 2025, the top-performing product for Chime & Chill was the K.O. - CBD Double Dose Tincture (4500mg CBD, 30ml) in the Tincture & Sublingual category, maintaining its first-place ranking for four consecutive months, although its sales slightly decreased to 181 units. The K.O- CBD The Money Melon Distillate Disposable (1g) in the Vapor Pens category showed notable improvement, climbing to the second position from fourth in November, with consistent sales of 157 units. The CBD/CBN 2:1 PM Lotion (300mg CBD, 150mg CBN) retained its third-place standing, continuing its strong performance in the Topical category. Meanwhile, the CBD Hello Honeydew Live Resin Cartridge (1g) slipped to fourth place from second in November, indicating a slight dip in its competitive edge. The CBD/CBG 2:1 AM Body Cream (300mg CBD, 150mg CBG) reappeared in the rankings at fifth place, suggesting a resurgence in interest or availability after a month absence.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







